Form 483

Sanofi Winthrop Industrie Form 483, 2016-10-31

FDA issued a Form 483 to Sanofi Winthrop Industrie on 2016-10-31 with 3 public-safe observations.

483· Form 483 issuedHuman Drugs3 observations

Sanofi Winthrop Industrie · Maisons Alfort, France · Issued October 31, 2016

Overview

  • 3 public-safe observations are available for this inspection.
  • 3 structured CFR citations are represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

31 Oct 2016
21 CFR 211.100(a)

Changes to Procedures Not Reviewed, Approved

Cited by Satheesh Thomas, Xiaoping Guan

31 Oct 2016
21 CFR 211.25(a)

Training , Education , Experience overall

Cited by Satheesh Thomas, Xiaoping Guan

31 Oct 2016
21 CFR 211.165(e)

Test methods

Cited by Satheesh Thomas, Xiaoping Guan

Inspected site

SWSanofi Winthrop IndustrieMaisons Alfort, France

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.100(a)Cited across public-safe Form 483 observations1x
21 CFR 211.165(e)Cited across public-safe Form 483 observations1x
21 CFR 211.25(a)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 3 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere